| |
Control subjects
(n = 230) |
Extremely obese patients
(n = 335) |
p value |
| Age [years] |
49.90 ± 16.30 |
54.13 ± 11.98 |
< 0.001 |
| Male/female [%] |
33.91 / 66.09 |
35.22 / 64.78 |
0.955 |
| BMI [kg/m2] |
24.04 ± 2.33 |
44.82 ± 5.51 |
< 0.001 |
| WHR: Women |
0.7971 ± 0.0787 |
0.9475 ± 0.0720 |
< 0.001 |
| WHR: Men |
0.9063 ± 0.0875 |
1.0217 ± 0.0613 |
< 0.001 |
| Hypertension [%] |
33.33 |
88.89 |
< 0.001 |
| SBP [mm Hg] |
115.60 ± 26.53 |
123.67 ± 8.86 |
< 0.001 |
| DBP [mm Hg] |
70.72 ± 21.32 |
78.52 ± 3.95 |
< 0.001 |
| Fasting glucose [mg/dL] |
95.37 ± 12.84 |
120.90 ± 33.05 |
< 0.001 |
| T2DM % |
0 |
60.00 |
< 0.001 |
| TC [mg/dL] |
207.45 ± 46.38 |
203.39 ± 57.23 |
<0.05 |
| LDL-C [mg/dL] |
124.39 ± 40.52 |
117.00 ± 43.12 |
<0.05 |
| HDL-C [mg/dL] |
63.14 ± 17.58 |
52.93 ± 16.65 |
< 0.001 |
| TG [mg/dL] |
110.72 ± 66.54 |
153.02± 75.27 |
< 0.001 |
|
| Data are presented as mean ± SD (standard deviation), BMI: Body Mass Index;WHR: Waist To Hip Ratio; SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure; T2DM: Type 2 Diabetes Mellitus; TC: Total Cholesterol; LDL-C: Low-Density Lipoproteins; HDL-C: High-Density Lipoproteins; TG: Triglicerydes. |
| Table 1: Clinical and biochemical characteristics of the extremely obese patients and control subjects. |
